Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice

Journal of Clinical Pathology

Volumn 64, Issue 4, 2011, Pages 308-312

  Thavaraj, Selvam ^a   Stokes, Angela ^a   Guerra, Eliete ^b   Bible, Jon ^c   Halligan, Eugene ^c   Long, Anna ^d   Okpokam, Atuora ^d   Sloan, Philip ^d,e   Odell, Edward ^a   Robinson, Max ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER DNA; PROTEIN P16; VIRUS DNA;

ADULT; AGED; ARTICLE; CLASSIFICATION ALGORITHM; CLINICAL PRACTICE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION RISK; MALE; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PATHOLOGIST; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SERODIAGNOSIS; SEX RATIO; TONSIL; VIRAL GENETICS; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEASIBILITY STUDIES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; TONSILLAR NEOPLASMS;

EID: 79953107664     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.088450     Document Type: Article

References (19)

1. IACR Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomavirus: IACR Monographs Volume 90. Geneva: WHO Press, 2007:1-636.
2. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121:1813-20. (Pubitemid 47417302)
3. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-9. (Pubitemid 351480538)
4. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
5. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781-9.
6. Braakhuis BJ, Brakenhoff RH, Meijer CJ, et al. Human papillomavirus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. Eur J Cancer 2009;45:2935-9.
7. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465-72. (Pubitemid 350022416)
8. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010;116:2166-73.
9. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
10. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/GP6 +-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5. (Pubitemid 27083888)
11. Snijders PJ, Heideman DA, Meijer CJ. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS 2010;118:520-8.
12. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91. (Pubitemid 18084310)
13. White JS, Weissfeld JL, Ragin CC, et al. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 2007;43:701-12. (Pubitemid 47058372)
14. Geraets DT, Heideman DA, de Koning MN, et al. High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology. J Clin Virol 2009;46:S21-6.
15. Pindborg JJ, Reichart PA, Smith CJ, et al. Histological Typing of Cancer and Precancer of the Oral Mucosa. 2nd edn. Berlin: Springer, 1997:11-13.
16. Klingenberg B, Hafkamp HC, Haesevoets A, et al. p16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV. Histopathology 2010;56:957-67.
17. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24:736-47. (Pubitemid 46622040)
18. Lewis JS, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010;34:1088-96.
19. Department of Health. Report of the Review of NHS Pathology Services in England. 2006. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4137606 (accessed Dec 2010).